Sutro Biopharma Inc (STRO)

Is Sutro Biopharma Inc (STRO) A Buy Now?

According to our latest analysis, STRO could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on STRO, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 42.43 indicates that STRO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 72.81 indicates that STRO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.25 indicates that STRO is overbought. This suggests that STRO price is at or near the highest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 48.96 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
5. CCI (Commodity Channel Index): A CCI(14) value of 39.76 indicates that STRO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term STRO price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Sutro Biopharma Inc financial reports and earnings history, Sutro Biopharma Inc (STRO) stock could reach $59.19 by 2030, $341.99 by 2040 and $780.57 by 2050. See the projected annual prices until 2050 of the Sutro Biopharma Inc stock below:

• Sutro Biopharma Inc (STRO) is expected to reach an average price of $131.51 in 2035, with a high prediction of $173.46 and a low estimate of $125.42. This indicates an +1,182% change from the last recorded price of $10.26.
• Sutro Biopharma Inc (STRO) stock is projected to chart a bullish course in 2040, with an average price target of $260.72, representing an +2,441% change from its current level. The forecast ranges from a conservative $253.37 to a sky-high $341.99.
• Our analysts predict Sutro Biopharma Inc (STRO) to change +4,149% by 2045, soaring from $439.35 to an average price of $436.00, potentially reaching $527.66. While $439.35 is the low estimate, the potential upside is significant.
• Sutro Biopharma Inc (STRO) stock is expected to climb by 2050, reaching an average of $633.90, a +6,078% change from its current level. However, a wide range of estimates exists, with high and low targets of $780.57 and $634.50, respectively, highlighting the market's uncertainty.

Sutro Biopharma Inc Stock (STRO) Year by Year Forecast